동아제약's prominent inner beauty brand, AILO, is accelerating its global 확장 by officially entering the U.S. offline 시장 in partnership with Olive Young, a leading K-beauty retail platform. Building on its successful 판매 성과 across Olive Young's domestic and international channels, AILO plans to introduce its specialized inner beauty 제품을 to American consumers. This 전략적 move is expected to serve as a 핵심 springboard for showcasing the K-inner beauty 우수성을 to the global 시장.
AILO Launches in Olive Young Pasadena, Commencing U.S. Offline Market Expansion
동아제약's inner beauty brand, AILO, has announced its U.S. offline 시장 진출 with its official 입점 at the Olive Young Pasadena store in California. This 전략적 move into the American 시장 was driven by AILO's outstanding 판매 성과 and robust 브랜드 성장 observed across Olive Young's domestic stores and its global online mall. Leveraging high customer satisfaction within Olive Young channels, AILO aims to provide local consumers with its unique and differentiated inner beauty 제품.
Through its 진출 into Olive Young Pasadena, 동아제약 intends to enhance the 접근성 of AILO 제품 and expand its engagement with local consumers, thereby strengthening 인지도. The 협력 with Olive Young, a leader in K-beauty, is expected to play a 핵심 역할 in AILO's successful establishment in the U.S. 시장. To maximize online and offline synergy, AILO 제품 will also be available simultaneously on local online malls, further accelerating the brand's 시장 공략.
AILO's Key Product Lineup for the U.S. Market
A total of five AILO 제품, including the brand's signature 품목 and innovative inner beauty 제품, will be available at Olive Young Pasadena. 핵심 제품 include the 'Type 1 Collagen Biotin Ampoule (8-count)' and 'Dual Slim Cut (60 tablets).' Additionally, 'Whitathione (30 sachets),' 'Mucin Collagen Jelly (10 sachets),' and 'Kamut Enzyme (30 sachets)' are slated to be introduced to local consumers.
The 'Type 1 Collagen Biotin Ampoule' is a flagship 제품 embodying 동아제약's concentrated technology, having garnered significant 인기 and recognition for its 우수성 in domestic Olive Young stores. The 'Dual Slim Cut,' formulated with a scientific 배합, is also rapidly expanding its 영향력 in the slimming 시장 and is expected to capture the attention of U.S. consumers pursuing healthy beauty. These 제품 will play a 핵심 역할 in conveying AILO's commitment to professional inner beauty 가치.
Dong-A Pharm's Vision: Evolving into a Global Healthcare Leader
동아제약 stated that AILO's U.S. 시장 진출 is a valuable 성과 made possible by customers who have trusted and chosen their 제품 across Olive Young's domestic and international channels. The 기업 emphasized its 의지 to promoting the 우수성 of K-inner beauty to the global 시장 through close 협력 with CJ Olive Young. This initiative underscores 동아제약's dedication to providing professional healthcare experiences to consumers worldwide.
Beyond its U.S. 시장 진출, 동아제약 has 지속적 확장 its presence in international 시장, exporting its flagship 제품군 to major 전략적 거점 across Asia and globally, including China, Japan, Vietnam, and Mongolia. Recently, the 기업 has been actively broadening its local offline 유통망, moving beyond online channels, thereby accelerating its 성장 as a global healthcare 기업. AILO's U.S. 시장 진출은 an 일환 of 동아제약's overarching global 전략, serving as a catalyst to solidify its 입지 as a world-leading healthcare innovator.
